Literature DB >> 26613238

Synthesis of New Congeners of 1-methyl-3-aminoisoquinolines, Evaluation of Their Cytotoxic Activity, In Silico and In Vitro Study of Their Molecular Targets as PDE4B.

Gennady B Lapa1,2, Toshiyuki Tsunoda3,4, Senji Shirasawa3,4, Maria A Baryshnikova1, Gregory G Evseev1, Daria A Afanasyeva1, Elena A Chigorina5.   

Abstract

To examine the cytotoxic activity of congeners of 3-amino-isoquinoline, we performed the phenotypic screening using panel of 60 cell lines and found that (N-(6,7-dimethoxy-1-methyl-isoquinolin-3-yl)-4-{[(1-ethyl-4-methyl-1H-pyrazol-3-yl)methyl]amino}benzamide (4d)) exhibited the significant effect against different tumor cell lines while showing the high activity toward human colorectal cancer HCT-116 cells (IC50 = 18 μm) and human breast cancer T-47D cells (GI50 = 1.9 μm). Virtual screening indicated that these compounds target protein kinases and phosphodiesterases (PDE). However, wet screening among panel of protein kinases did not show any significant activity. By contrast, 50 μm of 4c and 4d inhibited the growth of HKe3-mtKRAS spheroids in the 3D floating (3DF) culture suggesting that 4c and 4d target PDE4B which is selectively upregulated by mtKRAS in 3DF culture.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  3-amino-isoquinoline; 3D floating culture; HCT116; HKe3; K562; KRAS; PDE; T-47D; breast cancer; colorectal cancer; cytotoxic activity; leukemia; phenotypic screening; phosphodiesterase; reversal docking; virtual screening

Mesh:

Substances:

Year:  2015        PMID: 26613238     DOI: 10.1111/cbdd.12691

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  2 in total

Review 1.  PDE4 subtypes in cancer.

Authors:  Samuel Hsien Lai; Guston Zervoudakis; Jesse Chou; Mark E Gurney; Kelly M Quesnelle
Journal:  Oncogene       Date:  2020-03-20       Impact factor: 9.867

2.  A facile metal-free one-pot synthesis of 3-aminoisoquinolines by intramolecular transannulation of 1-sulfonyl-4-(2-aminomethylphenyl)-1,2,3-triazoles.

Authors:  Hai Shang; Ling-Yu Li; Yu Tian; Hong-Mei Jia; Zhong-Mei Zou
Journal:  RSC Adv       Date:  2020-10-28       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.